Karsta Luettich
Philip Morris International (Switzerland)(CH)
Publications by Year
Research Areas
Air Quality and Health Impacts, Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, 3D Printing in Biomedical Research, Innovative Microfluidic and Catalytic Techniques Innovation
Most-Cited Works
- → Variability of Antioxidant-Related Gene Expression in the Airway Epithelium of Cigarette Smokers(2003)199 cited
- → A lung/liver-on-a-chip platform for acute and chronic toxicity studies(2018)180 cited
- → Human multi-organ chip co-culture of bronchial lung culture and liver spheroids for substance exposure studies(2020)113 cited
- → Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking(2006)103 cited
- → Mitochondria as a possible target for nicotine action(2019)101 cited
- → Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity(2018)93 cited
- → Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects(2015)86 cited
- → Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency(2004)84 cited
- Monoallelic up-regulation of the imprinted H19 gene in airway epithelium of phenotypically normal cigarette smokers.(2003)
- → Assessment of mitochondrial function following short- and long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product and reference cigarettes(2018)58 cited